State Councilor and Foreign Minister Wang Yi (right) shakes hands with Ri Yong-ho, foreign minister of the Democratic People's Republic of Korea, on Tuesday in Beijing. [Wang Zhuangfei/China Daily] State Councilor and Foreign Minister Wang Yi said on Tuesday that China supports Pyongyang's upcoming summit meetings with Seoul and Washington and that China will continue to work for denuclearization and the establishment of a peace mechanism on the Korean Peninsula. Wang made the remark while meeting with Ri Yongho, foreign minister of the Democratic People's Republic of Korea on Tuesday in Beijing. Wang said that during top DPRK leader Kim Jong-un's recent visit to China, Xi Jinping, general secretary of the Communist Party of China Central Committee, reached a consensus with Kim on developing China-DPRK relations and on promoting the peaceful settlement of the Korean Peninsula nuclear issue. In current situation, maintaining and developing the traditional friendship between China and the DPRK is important for both countries and the region, Wang said. The diplomatic departments of both countries should strengthen exchanges at all levels and translate into reality the outcomes of the two leaders' meeting as soon as possible, Wang said. Ri said the meeting of the two top leaders has provided an important opportunity for the development of DPRK-China relations. The DPRK is willing to work with China to implement the consensus of the top leaders, boost mutual high-level visits and diplomatic communication at all levels, and inherit and develop DPRK-China traditional, friendly relations, Ri said. Wang said China hails the DPRK's commitment to denuclearization of the peninsula and the important efforts it has made to ease the peninsula situation. Ri said the DPRK will work as guided by the meeting between the two top leaders and maintain close strategic communications with China. According to Foreign Ministry spokesman Geng Shuang, Ri was stopping over in Beijing, which comes just a week after Kim's trip to the Chinese capital. In a joint news conference with visiting Swiss Foreign Minister Ignazio Cassis, Wang called on all sides to maintain focus, eliminate interference and firmly follow the correct path of dialogue and negotiation to solve the nuclear issue on the Korean Peninsula. Recently, the situation has undergone positive changes and relevant parties have conducted positive interactions, Wang said. China hopes all sides can cherish the hard won situation on the peninsula, maintain the momentum of contact and dialogue, and create conditions to smoothly restart dialogue, he said. But he warned that historical experience has shown that at the moment of easing of the situation and as first light dawns on peace and dialogue, frequently all manner of disruptive factors emerge. He said he hoped that disruptive factors will be overcome and neither side will be distracted. where can i buy yellow wristbandsjelly band silicone medical alert braceletpaw print silicone braceletspink breast cancer silicone wristbandscheap custom rubber bracelets no minimum
[Photo/VCG] Stronger penalties proposed to curtail falsification, substandard products People who produce and sell medicines illegally in China could face heavier penalties under a draft amendment to intensify supervision to protect public health. Companies that produce or sell pharmaceuticals without a permit, or that produce or sell fake drugs, will face fines up to 30 times the value of the products involved, according to the draft amendment to the Drug Management Law. Existing law provides for fines of up to five times the value. Producing or selling fake drugs will result in the suspension of business and revoked certificates, while the production or sale of substandard drugs will result in fines of up to 15 times the value of the products produced or sold, and may result in other penalties such as business suspension or revoked permits. Current law calls for maximum fines in such cases of three times the value of the products involved. In addition to fines, perpetrators may also face criminal sentences. The measures are intended to increase punishments for violations of the law - to solve problems in supervision such as the current weak punishments for violators, Jiao Hong, chief of the National Medical Products Administration, China's top drug regulator, said on Monday at a conference while elaborating on the draft revision to members of the NPC Standing Committee. Officials in charge of drug supervision will also face heavier punishments in case of violations involving drugs, the amendment said. Production or sale of some special types of drugs - such as vaccines and drugs meant for children and pregnant women - will be subject to tougher penalties, it said. In addition, drug producers must immediately recall drugs from the market if they have quality or safety risks, and information about the recall should be shared with the public and drug authorities. The draft amendment was written after a vaccine scandal involving Changchun Changsheng Bio-tech Co, a major vaccine producer in Jilin province, to counter violations of the law and irregularities in the production and distribution chains in the pharmaceutical sector. In the vaccine scandal, the company was ordered last week by the National Medical Products Administration to pay fines of 9.1 billion yuan ($1.3 billion) for violations involving the fabrication of production records and using expired materials in a rabies vaccine. Senior executives of the company have been referred to judicial organs for criminal investigation, the administration said.
